ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000253513.1	AKT inhibitor VIII	Chronic Lymphocytic Leukemia	0.019820924	Resistant
ENSG00000253513.1	AKT inhibitor VIII	Bladder urothelial carcinoma	0.01457273	Sensitive